Watch CBS News

No Rest For The Weary

Dozens of chimpanzees from a Dutch research laboratory face a housing crisis after plans for their early retirement on the Spanish coast collapsed because of residents' fears they would carry infectious diseases.

The simian saga illustrates the dilemma of what to do with research chimps as more countries decide it is no longer acceptable to use humankind's closest genetic relative for experiments.

The Dutch government agreed to pay for 39 healthy chimps to move to a proposed state-of-the-art facility near the tiny town of Relleu, Spain. The center, to be built on 103 acres of land, was to feature trees, play structures, and housing with shady areas underneath.

But Relleu has refused to grant a building permit, due to residents' fears that the chimps carry diseases. Pleas from the Spanish regional government, and a personal visit in July from renowned chimpanzee expert Jane Goodall have failed to sway town officials.

"We are in trouble, that's for sure," said David van Gennep, director of Stichting AAP, the Dutch primate shelter behind the proposed move.

The 39 chimps "could end up spread around the world. But we're not willing to accept having them put them down," he said.

Chimps can be traumatized if separated or combined with other groups, research shows. Caring for them is also costly, and high-quality zoos are reluctant to accept laboratory chimps because they may have developed psychological problems.

The 39 chimps were part of a major colony living at the Biomedical Primate Research Center in 2002 when the Dutch government forbade any further testing on chimpanzees after trials already in progress ended.

New Zealand and Britain have made similar decisions under intense pressure from animal rights groups. The U.S. Congress voted in 2000 to allow primate testing to continue, but with restrictions.

The U.S. government in 2000 put aside $24 million to fund a centralized refuge for laboratory chimps in Shreveport, Louisiana, that will eventually house 300 former research chimps.

But Europe has no parallel facility and funding is another problem.

At the Dutch research center — which was Europe's last remaining lab using chimps for research — 70 other healthy chimps have been sold or promised to seven different European zoos and animal centers of mostly high standards.

But one of those projects has run into funding trouble and may not be ready to receive its 20 chimps in time.

Another 23 infected with HIV and Hepatitis C will be housed at a closed facility in the Netherlands.

In Austria, the U.S.-based Baxter International, Inc. sold a group of 46 former research chimps from its private research laboratory to a safari park in 2003.

But the Ganserndorf Safari Park has now gone bankrupt and those chimps are in danger of being sold by curators to the highest bidder, including low-quality zoos — or research laboratories in Asia, where primate research is still allowed.

Earlier this year, the Dutch health minister threatened to halt the Spanish move when he heard it would cost the government about $16,000 per chimp per year — more than some humans get in social security benefits.

Health Minister Hans Hoogervorst, who took office after the 2002 settlement was reached, described the cost as "rather insane" during a period of budget cuts.

"They can just be put into Dutch zoos, right? Maybe it's not Marbella (a Spanish resort), but it's not a bad life, right?" he said.

Van Gennep said the plan did not entail needless luxury: Spain's warmer climate and cheaper living costs made it more affordable than keeping the chimps in rainy Holland.

By comparison, housing the 23 chimps infected with HIV and Hepatitis C in the Netherlands will cost around $53,000 per chimp per year.

Hoogervorst later dropped his objections.

"People have the feeling that they've done a great good by ending experimentation, but there's not enough space for more chimps in existing facilities," Van Gennep said.

"This is a problem around Europe and it needs a central solution."

View CBS News In
CBS News App Open
Chrome Safari Continue